Glenn L. Cooper M.D. is Director at REPLIGEN CORP (RGEN). They have made 6 open-market trades across 3 companies since 2006, most recently 2019-05-23.
CIK 0001046351
5 open-market purchases totalling $213K since 2006, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGEN | SELL | 2019-05-23 | 2019-06-19 | $66.93 | $651K | +4.7% | +5.6% | -1.4% |
| CNDO | BUY | 2012-11-30 | 2012-12-03 | $4.02 | $15K | N/A | N/A | N/A |
| RGEN | BUY | 2012-09-21 | 2012-09-24 | $6.09 | $61K | -17.5% | +0.7% | +0.7% |
| CNDO | BUY | 2012-06-22 | 2012-06-26 | $5.30 | $53K | N/A | N/A | N/A |
| RGEN | BUY | 2009-11-09 | 2009-11-17 | $4.98 | $25K | -17.5% | +0.7% | +0.7% |
| IDEV | BUY | 2006-01-09 | 2006-01-09 | $5.85 | $59K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.